TC
VYNT

TFS Capital’s Vyant Bio, Inc. Common Stock VYNT Stock Holding History

TFS Capital’s Portfolio VYNT Stock Details VYNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-285
Closed -$484K – 1267
2014
Q2 		$484K Buy
285
+189
+197% +$360K 0.04% 656
2014
Q1 		$217K Sell
96
-184
-66% -$471K 0.01% 1156
2013
Q4 		$580K Buy
+280
New +$605K 0.03% 761

Other funds holding VYNT

Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $304B AUM 35.64% 1-Year Est. Return
CM
Castleark Management Chicago, Illinois $3.71B AUM 65.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NC
Northpointe Capital Bloomfield Hills, Michigan $258M AUM 1.97% 1-Year Est. Return
GMCM
Gruber & McBaine Capital Management San Francisco, California $369M AUM 12.23% 1-Year Est. Return
SIM
SSI Investment Management Los Angeles, California $1.72B AUM 7.09% 1-Year Est. Return
SCM
Sterneck Capital Management Kansas City, Missouri $233M AUM 21.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
DM
Diker Management New York $130M AUM 97.77% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

TFS Capital's VYNT Position: Q3 2014 in Review

TFS Capital sold out of Vyant Bio, Inc. Common Stock (VYNT) in Q3 2014, closing a stake of 285 shares — an estimated $484K sold.

TFS Capital first reported a position in VYNT in Q4 2013 and held it in 3 quarters. The position peaked at $580K in Q4 2013. 28 funds tracked by Wall St. Rank hold VYNT as of Q3 2014.

  • TFS Capital reported no remaining Vyant Bio, Inc. Common Stock position as of Q3 2014 after selling out during the quarter.
  • TFS Capital sold 285 Vyant Bio, Inc. Common Stock shares in Q3 2014, an estimated $484K.
  • TFS Capital first reported a position in Vyant Bio, Inc. Common Stock in Q4 2013 and held it in 3 quarters.
  • TFS Capital's Vyant Bio, Inc. Common Stock position peaked at $580K in Q4 2013.
  • 28 funds tracked by Wall St. Rank held Vyant Bio, Inc. Common Stock as of Q3 2014.

Based on TFS Capital's 13F filing for Q3 2014, filed 6 Nov 2014.